Efficiency of live attenuated and inactivated rabies viruses in prophylactic and post exposure vaccination against the street virus strain.

Abstract

Rabies remains an enigmatic and widely discussed global infectious disease and causes an increasing number of deaths. The currently used highly effective prophylactic and post exposure (p.e.) vaccination depends solely upon inexpensive, effective and safe vaccines to counteract the spread of the disease. In this study, the potential of an attenuated Chinese rabies vaccine (SRV9) strain in prophylactic and p.e. vaccination against the street strain of rabies virus (RV) was evaluated in mice. Prophylactic vaccination consisting of one intramuscular (i.m.) dose of SRV9 protected 100% of mice from intracerebral (i.c.) challenge with a lethal dose of the street virus. The latter was detected in the brain of mice at day 6 post challenge by RT-PCR. Post exposure vaccination was performed at days 1, 2, 3, 4, 5 and 6 post infection (p.i.) with either SRV9 or inactivated rabies vaccine. The survival rates after i.m. inoculation of SRV9 at the indicated days were 70%, 50%, 30%, 20%, 10%, and 0%, respectively; the corresponding survival rates for the inactivated rabies vaccine were 30%, 20%, 10%, 0%, 0%, and 0%, respectively. However, 100%, 90%, 70%, 50%, 20%, 10%, and 10% of mice survived after i.c. inoculation of SRV9 at the indicated days. The increased permeability of the blood-brain barrier and the infiltration of CD19+ B cells into the central nervous system after i.c. inoculation of SRV9 are regarded as prerequisites for the clearance of the street virus. The obtained data suggest that SRV9 is a promising candidate for prophylactic and p.e. vaccination against rabies infection and that it exhibits a potential for the control of rabies in China.

• Authors: F Huang, W Ahmad, M Duan, Z Liu, Z Guan, M Zhang, B Qiao, Y Li, Y Song, Y Song, Y Chen, M Amjad Ali
• Journal: Acta virologica (Acta Virol) Vol. 59 Issue 2 Pg. 117-24 (Jun 2015) ISSN: 0001-723X [Print] Slovakia
• PMID: 26104328 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Antigens, CD19
• Rabies Vaccines
• Vaccines, Attenuated
• Vaccines, Inactivated

Topics

• Animals
• Antigens, CD19 (genetics, immunology)
• Female
• Humans
• Mice
• Mice, Inbred ICR
• Post-Exposure Prophylaxis
• Rabies (immunology, mortality, prevention & control, virology)
• Rabies Vaccines (administration & dosage, genetics, immunology)
• Rabies virus (genetics, immunology)
• Vaccination
• Vaccines, Attenuated (administration & dosage, genetics, immunology)
• Vaccines, Inactivated (administration & dosage, genetics, immunology)